Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The latest announcement is out from Cannara Biotech ( (TSE:LOVE) ).
Cannara Biotech has completed a strategic C$6.3 million non-brokered private placement with Phoenician Capital, issuing 3 million common shares at C$2.10 per share, a roughly 16% premium to its last closing price, to fund working capital, continued investment in its Valleyfield facility, expansion of operations and to preserve balance-sheet flexibility. The deal deepens Cannara’s institutional shareholder base with a long-term investor aligned on governance and growth, while CEO and chairman Zohar Krivorot separately agreed to sell 333,333 shares to Phoenician in a secondary transaction for personal tax-loss reasons, modestly reducing his stake but keeping him a significant shareholder, and the company also reported that all director nominees were elected at its recent annual general and special meeting.
The most recent analyst rating on (TSE:LOVE) stock is a Hold with a C$2.00 price target. To see the full list of analyst forecasts on Cannara Biotech stock, see the TSE:LOVE Stock Forecast page.
Spark’s Take on TSE:LOVE Stock
According to Spark, TipRanks’ AI Analyst, TSE:LOVE is a Neutral.
The score is driven primarily by solid financial performance—healthy margins, steady revenue growth, and improving leverage—offset by weaker/less consistent free cash flow. Technicals are mixed with neutral momentum and slight short-term softness, while valuation appears reasonable based on the P/E.
To see Spark’s full report on TSE:LOVE stock, click here.
More about Cannara Biotech
Cannara Biotech Inc. is a vertically integrated producer of premium-grade cannabis products at affordable prices, operating two mega facilities in Québec spanning more than 1.6 million square feet. The company focuses on scaling its cultivation and processing capacity within the Canadian cannabis market while maintaining operational discipline and cost-effective production.
Average Trading Volume: 53,500
Technical Sentiment Signal: Buy
Current Market Cap: C$164.7M
See more data about LOVE stock on TipRanks’ Stock Analysis page.